Curious to see your top suppliers emissions?
Book a demo for a pilot project
KALA BIO, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 1 year agokalarx.com
KALA BIO, Inc., a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative therapies for patients with serious diseases. Founded in 2018, the company has quickly established itself in the biopharmaceutical industry, particularly in the realm of gene therapy and precision medicine.
KALA BIO's core offerings include advanced gene delivery systems designed to enhance therapeutic efficacy and safety. Their unique approach leverages proprietary technology to address unmet medical needs, setting them apart in a competitive market. With a commitment to scientific excellence, KALA BIO has achieved significant milestones, positioning itself as a leader in the development of transformative treatments. The company continues to expand its operational footprint, aiming to make a lasting impact on patient care globally.
18
DitchCarbon score
-22 vs industry average
KALA BIO, Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at KALA BIO, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for KALA BIO, Inc. yet.
KALA BIO, Inc.'s reported carbon emissions
KALA BIO, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that KALA BIO, Inc. may not have established formal climate initiatives or targets at this time. As the company operates within the biopharmaceutical industry, it is essential for them to consider developing a comprehensive climate strategy to align with industry standards and expectations for sustainability.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
KALA BIO, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for KALA BIO, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
KALA BIO, Inc.1 year ago
18
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more